| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |